This infra stock, which undertakes turnkey EPC contracts and BOT projects, jumped up to 5 percent in the day’s trade upon receiving a new work order worth Rs. 1,480 crore from Bihar Medical Services Corp.
Stock Performance
With a market capitalization of Rs. 13,225.59 crores, the shares of NCC Ltd went up nearly 5 percent to an intraday high of Rs. 215.95 per share compared to the previous closing price of Rs 206.05.
The stock retraced and was trading at Rs. 210.65, marking a 2 percent increase from the previous close.
What Happened
NCC Ltd received a work order of Rs. 1,480.34 crore from Bihar Medical Services & Infrastructure Corporation Limited for the Redevelopment of Darbhanga Medical College & Hospital (DMCH) along with other buildings at the campus of DMCH. The tenure for construction is set at 42 months and for DLP at 36 months.
Company Overview
NCC Limited (formerly known as Nagarjuna Construction Company Limited) is a large Construction and Infrastructure Development Company. They have been participating in various tenders floated on a regular basis and bagging contracts with major clients including Adani, IOC, MMRC, RVNL and NHAI.
Financials
Looking at the latest financial performance, the company reported a muted 2 percent increase in revenue from Rs 5,260 crore in Q3 FY24 to Rs 5,345 crore in Q3 FY25. This was accompanied by a 14 percent decline in net profits from Rs 231 crore to Rs 206 crore during the same period.
Order Book Analysis
The company has a diversified order book of Rs.55,548 crores. The order inflow for Q3 FY25 stood at Rs. 8,440 crores. About 38 percent of the company’s order book comes from buildings.
Other prominent businesses being Transportation, Electrical (T&D), Water and Railways, Irrigation, Mining and so on. State wise, maximum orders for the company come from areas like Maharashtra, Uttar Pradesh, Karnataka and others.
Written by Shwetha Sairam
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
